Abstract
This work reports the magnetite-functionalization and biological evaluation of eugenol by the co-precipitation method employed only Fe2+ under mild conditions and control from the amount of the incorporated magnetite. Magnetic nanoparticles were characterized by scanning electron microscopy (SEM), X-ray diffraction (XRD), Fourier transform infrared (FTIR), hydrodynamic size distribution (Zetasizer), and vibrating sample magnetometer (VSM). SEM images showed that EUG·Fe3O4 similar in shape to a nanoflower. The FTIR spectrum confirmed the presence of characteristic EUG and Fe3O4 bands in the EUG·Fe3O4 sample, the XRD analysis showed that the magnetite functionalization with eugenol slightly affected the Fe3O4 crystal structure, while the VSM measurements demonstrate that EUG·Fe3O4 1:1 shows a superparamagnetic behavior, suggesting small non-interacting particles. The in vitro safety profile and cytotoxicity of free eugenol, magnetite pristine, EUG·Fe3O4 1:1, EUG·Fe3O4 1:5, and EUG·Fe3O4 1:10 was investigated using human cell lines (keratinocytes and melanoma). The results demonstrate the high biocompatibility of EUG·Fe3O4 in HaCat cells and the greater specificity for the A375 cell line. Furthermore, the magnetite-functionalization with eugenol decreased the toxic effects of free eugenol on healthy cells. Antibacterial tests were performed in different bacterial strains. The experimental data showed that among the magnetic compounds, the microorganisms were only sensitive to treatment with EUG·Fe3O4 1:1. Regarding the antibiofilm activity assay, it can be observed that only the EUG·Fe3O4 caused a significant decrease in biomass when compared to the positive control. Finally, it can be concluded that EUG·Fe3O4 proves to be a potential candidate for future studies for drug delivery of cancer and bacterial infections treatments.
Graphical Abstract
Similar content being viewed by others
References
M. Chidambaram, R. Manavalan, K. Kathiresan, Nanotherapeutics to overcome conventional cancer chemotherapy limitations. J. Pharm. Pharm. Sci. 14, 67–77 (2011)
S.Y. Wang, H.Z. Hu, X.C. Qing, Z.C. Zhang, Z.W. Shao, Recent advances of drug delivery nanocarriers in osteosarcoma treatment. J. Cancer. 1, 69–82 (2020)
C.R.B. Rhoden, F.S. Bruckmann, T.R. Salles, C.G. Kaufmann Jr., S.R. Mortari, Study from the influence of magnetite onto removal of hydrochlorothiazide from aqueous solutions applying magnetic graphene oxide. J. Water. Process. Eng. 43, 102262 (2021). https://doi.org/10.1016/j.jwpe.2021.102262
A.R. Viana, B. Salles, F.S. Bruckmann, L.M.F. Krause, S.R. Mortari, C.R.B. Rhoden, Cytotoxicity study of graphene oxide against vero lineage cells. Discip. Sci. Sér. Ciên. Nat. Tecnol. 20, 355–364 (2019)
T.R. Salles, H.B. Rodrigues, F.B. Bruckmann, L.C.S. Alves, S.R. Mortari, C.R.B. Rhoden, Graphene oxide optimization synthesis for application on laboratory of Universidade Franciscana. Discip. Sci. Sér. Ciên. Nat. Tecnol. 21, 15–26 (2020)
N.W. El Khayat, A.A. Donia, O.Y. Mady, G.M. El Maghraby, Optimization of eugenol microemulsion for transdermal delivery of indomethacin. J. Drug Deliv. Sci. Technol. 48, 311–318 (2018)
M. Lengyel, N. Kállai-Szabó, V. Antal, A.J. Laki, I. Antal, Microparticles, microspheres, and microcapsules for advanced drug delivery. Sci. Pharm. 87, 20 (2019). https://doi.org/10.3390/scipharm87030020
A. Kogan, N. Garti, Microemulsions as transdermal drug delivery vehicles. Adv. Colloid Interface Sci. 123, 369–385 (2006)
C. Altinkok, G. Acik, H.R.F. Karabulut, M. Ciftci, M.A. Tasdelen, A. Dag, A. Synthesis and characterization of bile acid-based polymeric micelle as a drug carrier for doxorubicin. Polym. Adv. Technol. 32, 4860–4868 (2021)
N. Shahabadi, A. Akbari, F. Karampour, M. Falsafi, Cytotoxicity and antibacterial activities of new chemically synthesized magnetic nanoparticles containing eugenol. J. Drug. Del. Sci. Technol. 49, 113–122 (2019)
F.S. Bruckmann, A.C. Pimentel, A.R. Viana, T.R. Salles, L.M.F. Krause, S.R. Mortari, C.R.B. Rhoden, Synthesis, characterization and cytotoxicity evaluation of magnetic nanosilica in L929 cell line. Discip. Sci. Sér. Ciên. Nat. Tecnol. 21, 1–14 (2020)
R. Vakili-Ghartavol, A.A. Momtazi-Borojeni, Z. Vakili-Ghartavol, H.T. Aiyelabegan, M.R. Jaafari, S.M. Rezayat, S. Arbabibidgoli, Toxicity assessment of superparamagnetic iron oxide nanoparticles in different tissues. Artif. Cells. Nanomed. Biotechnol. 48, 443–451 (2020)
L.H. Reddy, J.L. Arias, J. Nicolas, P. Couvreur, Magnetic nanoparticles: design and characterization, toxicity and biocompatibility, pharmaceutical and biomedical applications. Chem. rev. 112, 5818–5878 (2012)
P.U. Maheswari, R. Muthappa, K.P. Bindhya, K.M.S. Begum, Evaluation of folic acid functionalized BSA-CaFe2O4 nanohybrid carrier for the controlled delivery of natural cytotoxic drugs hesperidin and eugenol. J. Drug Deliv. Sci. Technol. 61, 102105 (2021). https://doi.org/10.1016/j.jddst.2020.102105
E. Talón, M. Vargas, A. Chiralt, C. González-Martínez, Antioxidant starch-based films with encapsulated eugenol. Application to sunflower oil preservation. Lwt 113, 108290 (2019)
F. Esmaeili, S. Rajabnejhad, A.R. Partoazar, S.E. Mehr, R. Faridi-Majidi, M. Sahebgharani, L. Syedmoradi, M.R. Rajabnejhad, A. Amani, Anti-inflammatory effects of eugenol nanoemulsion as a topical delivery system. Pharm. Dev. Technol. 21, 887–893 (2016)
T. Mosmann, Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65, 55–63 (1983)
E. Borenfreund, J.A. Puerner, Toxicity determined in vitro by morphological alterations and neutral red absorption. Toxicol. Lett. 24, 119–124 (1985)
A.W. Bauer, W.M. Kirby, J.C. Sherris, M. Turck, Antibiotic susceptibility testing by a standardized single disk method. Am. J. Clin. Pathol. 45, 493–496 (1966)
CLSI. (2015). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard-Tenth Edition. CLSI DOCUMENTE M07-A10. In Wayne, PA: Clinical and Laboratory Standards Institute.
S. Manner, M. Skogman, D. Goeres, P. Vuorela, A. Fallarero, Systematic exploration of natural and synthetic flavonoids for the inhibition of Staphylococcus aureus biofilms. Int. J. Mol. Sci. 14, 19434–19451 (2013)
L.Q.S. Lopes, C.G. Santos, R.A. Vaucher, R.P. Raffin, R.C.V. Santos, Nanocapsules with glycerol monolaurate: effects on Candida albicans biofilms. Microb. Pathog. 97, 119–124 (2016)
K. Pramod, C.V. Suneesh, S. Shanavas, S.H. Ansari, J. Ali, Unveiling the compatibility of eugenol with formulation excipients by systematic drug-excipient compatibility studies. J. Anal. Sci. Technol. 6, 1–14 (2015)
K.J. Datta, A.K. Rathi, V. Kumar, J. Kaslik, I. Medrik, V. Ranc, R.S. Varma, R. Zboril, M.B. Gawande, Synthesis of flower-like magnetite nanoassembly: application in the efficient reduction of nitroarenes. Sci. Rep. 7, 1–12 (2017)
S. Tanaka, Y.V. Kaneti, N.L.W. Septiani, S.X. Dou, Y. Bando, M.S.A. Hossain, J. Kim, Y. Yamauchi, A review on iron oxide-based nanoarchitectures for biomedical, energy storage, and environmental applications. Small Methods. 3, 1800512 (2019). https://doi.org/10.1002/smtd.201800512
Q. Wang, L. Zhang, W. Ding, D. Zhang, K. Reed, B. Zhang, Orthogonal optimization and physicochemical characterization of water-soluble gelatin-chitosan nanoparticles with encapsulated alcohol-soluble eugenol. Food Bioproc. Techol. 13, 1024–1034 (2020)
P.A. Hartley, G.D. Parfitt, L.B. Pollack, The role of the van der Waals force in the agglomeration of powders containing submicron particles. Powder Technol. 42, 35–46 (1985)
N. Lenin, A. Karthik, M. Sridharpanday, M. Selvam, S.R. Srither, S. Arunmetha, P. Paramasivam, V. Rajendran, Electrical and magnetic behavior of iron doped nickel titanate (Fe3+/NiTiO3) magnetic nanoparticles. J. Magn. Magn. Mater. 397, 281–286 (2016)
M. Gonzales, L.M. Mitsumori, J.V. Kushleika, M.E. Rosenfeld, K.M. Krishnan, Cytotoxicity of iron oxide nanoparticles made from the thermal decomposition of organometallics and aqueous phase transfer with Pluronic F127. Contrast. Media. Mol. imaging. 5, 286–293 (2010)
E. Catalano, In vitro biological validation and cytocompatibility evaluation of hydrogel iron-oxide nanoparticles. AIP Conf. Proc. 1873, 020011 (2017). https://doi.org/10.1063/1.4997140
R.M. Amin, A. Abdelmonem, T. Verwanger, E. Elsherbini, B. Krammer, Cytotoxicity of magnetic nanoparticles on normal and malignant human skin cells. Nano Life. 4, 1440002 (2014). https://doi.org/10.1142/S1793984414400029
C.G. Farcas, I. Macasoi, I. Pinzaru, M. Chirita, M.C. Chirita Mihaila, C. Dehelean, S. Avram, F. Loghin, L. Mocanu, V. Rotaru, A. Ieta, A. Ercuta, D. Coricovac, Controlled synthesis and characterization of micrometric single crystalline magnetite with superparamagnetic behavior and cytocompatibility/cytotoxicity assessments. Front. Pharmacol. 11, 410 (2020). https://doi.org/10.3389/fphar.2020.00410
R. Al Wafai, W. El-Rabih, M. Katerji, R. Safi, M. El Sabban, O. El-Rifai, J. Usta, Chemosensitivity of MCF-7 cells to eugenol: release of cytochrome-c and lactate dehydrogenase. Sci. Rep. 7, 1–13 (2017)
M. Pisano, G. Pagnan, M. Loi, M.E. Mura, M.G. Tilocca, G. Palmieri, D. Fabbri, M.A. Dettori, G. Delogu, M. Ponzoni, C. Rozzo, Antiproliferative and pro-apoptotic activity of eugenol-related biphenyls on malignant melanoma cells. Mol. cancer. 6, 1–12 (2007)
S.K. Jaganathan, E. Supriyanto, Antiproliferative and molecular mechanism of eugenol-induced apoptosis in cancer cells. Molecules 17, 6290–6304 (2012)
S.K. Jaganathan, A. Mazumdar, D. Mondhe, M. Mandal, Apoptotic effect of eugenol in human colon cancer cell lines. Cell. Biol. Int. 35, 607–615 (2011)
R. Ghosh, N. Nadiminty, J.E. Fitzpatrick, W.L. Alworth, T.J. Slaga, A.P. Kumar, Eugenol causes melanoma growth suppression through inhibition of E2F1 transcriptional activity. J. Biol. Chem. 280, 5812–5819 (2005)
J.A. Jacob, J.M.M. Salmani, B. Chen, Magnetic nanoparticles: mechanistic studies on the cancer cell interaction. Nanotechnol. Rev. 5, 481–488 (2016)
R.A. Revia, M. Zhang, Magnetite nanoparticles for cancer diagnosis, treatment, and treatment monitoring: recent advances. Mater. Today. 19, 157–168 (2016)
ISO, 10993–12. Biological evaluation of medical devices. Part 12: sample preparation and reference materials, ed. Geneva, Switzerland: International Organization for Standardization; 2009.
P.S.X. Yap, K. Yusoff, S.H.E. Lim, C.M. Chong, K.S. Lai, Membrane disruption properties of essential oils—a double-edged sword? Processes. 9, 595 (2021). https://doi.org/10.3390/pr9040595
L. Zhang, P.Y. Tan, C.L. Chow, C.K. Lim, O.K. Tan, M.S. Tse, C.C. Sze, Antibacterial activities of mechanochemically synthesized perovskite strontium titanate ferrite metal oxide. Colloids. Surf. A: Physicochem. Eng. Asp. 456, 169–175 (2014)
B. Das, D. Mandal, S.K. Dash, S. Chattopadhyay, S. Tripathy, D.P. Dolai, S.K. Dey, S. Roy, Eugenol provokes ROS-mediated membrane damage-associated antibacterial activity against clinically isolated multidrug-resistant Staphylococcus aureus strains. Infect. Dis. Res. Treat. 9, S31741 (2016). https://doi.org/10.4137/IDRT.S31741
F. Nazzaro, F. Fratianni, L. De Martino, R. Coppola, V. De Feo, Effect of essential oils on pathogenic bacteria. Pharmaceuticals. 6, 1451–1474 (2013)
R.A. Ismail, G.M. Sulaiman, S.A. Abdulrahman, T.R. Marzoog, Antibacterial activity of magnetic iron oxide nanoparticles synthesized by laser ablation in liquid. Mater. Sci. Eng. C. 53, 286–297 (2015)
S. Ma, S. Zhan, Y. Jia, Q. Zhou, Superior antibacterial activity of Fe3O4-TiO2 nanosheets under solar light. ACS Appl. Mat. Interfaces. 7, 21875–21883 (2015)
A. Marchese, R. Barbieri, E. Coppo, I.E. Orhan, M. Daglia, S.F. Nabavi, M. Izadi, M. Abdollahi, M.S. Nabavi, M. Ajami, Antimicrobial activity of eugenol and essential oils containing eugenol: A mechanistic viewpoint. Crit. Rev. Microbiol. 43, 668–689 (2017)
I. Negut, V. Grumezescu, A. Ficai, A.M. Grumezescu, A.M. Holban, R.C. Popescu, D. Savu, G. Socol, MAPLE deposition of Nigella sativa functionalized Fe3O4 nanoparticles for antimicrobial coatings. Appl. Surf. Sci. 455, 513–521 (2018)
H.B. Mohammed, S.M.I. Rayyif, C. Curutiu, A.C. Birca, O.C. Oprea, A.M. Grumezescu, L.M. Ditu, I. Gheorghe, M.C. Chifiriuc, G. Mihaescu, A.M. Holban, Eugenol-functionalized magnetite nanoparticles modulate virulence and persistence in pseudomonas aeruginosa clinical strains. Molecules 26, 2189 (2021). https://doi.org/10.3390/molecules26082189
M.K. Yadav, S.W. Chae, G.J. Im, J.W. Chung, J.J. Song, Eugenol: a phyto-compound effective against methicillin-resistant and methicillin-sensitive Staphylococcus aureus clinical strain biofilms. PLoS ONE 10, e0119564 (2015). https://doi.org/10.1371/journal.pone.0119564
N.A. Al-Shabib, F.M. Husain, I. Ahmad, M.H. Baig, Eugenol inhibits quorum sensing and biofilm of toxigenic MRSA strains isolated from food handlers employed in Saudi Arabia. Biotechnol. Biotechnol. Equip. 31, 387–396 (2017)
Z. Lou, K.S. Letsididi, F. Yu, Z. Pei, H. Wang, V. Letsididi, Inhibitive effect of eugenol and its nanoemulsion on quorum sensing–mediated virulence factors and biofilm formation by Pseudomonas aeruginosa. J. Food Prot. 82, 379–389 (2019)
Acknowledgements
The authors would like to thank Coordenação de Aperfeiçoamento de Pessoal de Nível Superior—Brasil (CAPES)—Finance Code 001, FAPERGS, CNPq, W.J.S. Garcia, A. Harres, and L.S. Dorneles from Laboratório de Magnetismo e Materiais Magnéticos—LMMM UFSM, and Universidade Franciscana for the support.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
da Silva Bruckmann, F., Viana, A.R., Lopes, L.Q.S. et al. Synthesis, Characterization, and Biological Activity Evaluation of Magnetite-Functionalized Eugenol. J Inorg Organomet Polym 32, 1459–1472 (2022). https://doi.org/10.1007/s10904-021-02207-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10904-021-02207-7